Effect of increased aortic blood pressure on myocardial performance and metabolism during non-adrenergic inotropic stimulation of the heart.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects*; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology*; D005942:Gluconates / Q000494:pharmacology; D006454:Hemoglobins; D007545:Isoproterenol / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D013268:Stimulation, Chemical
D005230:Fatty Acids, Nonesterified; D005942:Gluconates; D006454:Hemoglobins; D000804:Angiotensin II; D005934:Glucagon; D007545:Isoproterenol; D002118:Calcium